✅ Product Benefits & Highlights

• Combination therapy for glycemic control: Linagliptin (DPP‑4 inhibitor) enhances incretin hormones to boost insulin and suppress glucagon, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Meds BD+2Pharmacy Point+2Nibarok+2

• Flexible dosing options:

  • Immediate-release: initial dose 2.5 mg/500 mg twice daily; may escalate to 2.5 mg/1000 mg twice daily.

  • Extended-release: 5 mg/1000 mg once daily with meals. Incepta Pharma+3Pharmacy Point+3Meds BD+3

• Low-risk metabolic profile: Less hypoglycemia risk and weight neutrality compared to sulfonylureas. Pharmacist BD+7Nibarok+7MedicinesFAQ+7

• Once- or twice-daily dosing for convenience: Supports patient adherence when combined with meals. Pharmacy PointNibarok

• Affordable & locally produced: Each tablet priced at approximately ৳16 (~৳128 for an 8-tablet strip) and widely available across Bangladesh.